β‐Catenin and NF‐κB cooperate to regulate the uPA/uPAR system in cancer cells
Open Access
- 28 January 2011
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 128 (6) , 1280-1292
Abstract
Expression of the urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) has recently been shown to be directly regulated by the Wnt/β‐catenin signaling pathway in colon cancer cells, through β‐catenin binding to T‐cell factor binding element motifs present in their gene promoters. In our study, we present evidence that inhibition of β‐catenin causes upregulation of uPA/uPAR gene expression enhancing invasive potential. Using MCF‐7, MDA‐MB‐231 (breast cancer cells) and SW480 (colon cancer cells), we found that siRNA‐mediated silencing of β‐catenin increased uPA, uPAR and plasminogen activator inhibitor‐1 (PAI‐1) expression at the mRNA and protein levels. This increase was responsible for the observed enhanced invasive capacity of MDA‐MB‐231 and SW480 cancer cells. In addition, β‐catenin stabilization and accumulation by lithium chloride treatment, a well‐known inhibitor of glycogen synthase kinase‐3β (GSK‐3β), or by β‐catenin/T‐cell factor‐4 expression vectors transfection led to a decrease in uPA, uPAR and PAI‐1 mRNA expression in the studied cancer models. Treatment of β‐catenin siRNA‐transfected cells with a specific inhibitor of nuclear factor‐kappaB (NF‐κB), SN50, significantly reduced enhancement of uPA, uPAR and PAI‐1 expression and cancer cell invasion, observed in β‐catenin siRNA‐transfected cells. Furthermore, β‐catenin siRNA‐treated cells exhibited NF‐κB nuclear accumulation. These data suggest that β‐catenin regulates the uPA/uPAR system in cooperation with NF‐κB transcription factor, which constitutes a novel mechanism of regulation.Keywords
This publication has 32 references indexed in Scilit:
- Downregulation of E-cadherin is an essential event in activating β-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cellsOncogene, 2009
- The opposing roles of Wnt-5a in cancerBritish Journal of Cancer, 2009
- Genetic Mechanisms in Apc-Mediated Mammary TumorigenesisPLOS Genetics, 2009
- Gene silencing of β‐catenin in melanoma cells retards their growth but promotes the formation of pulmonary metastasis in miceInternational Journal of Cancer, 2008
- Differential effect of NF‐κB activity on β‐catenin/Tcf pathway in various cancer cellsFEBS Letters, 2008
- Fascin, a Novel Target of β-Catenin-TCF Signaling, Is Expressed at the Invasive Front of Human Colon CancerCancer Research, 2007
- Crossregulation of NF‐κB by the APC/GSK‐3β/β‐catenin pathwayMolecular Carcinogenesis, 2004
- Tumour-cell invasion and migration: diversity and escape mechanismsNature Reviews Cancer, 2003
- GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with AxinOncogene, 2000
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996